Symbol | Exchange | Currency |
|---|
Chardan Capital analyst Geulah Livshits reiterated a Buy rating on uniQure (NASDAQ:QURE) N.V. on Thursday, setting a price target of $95, which is approximately 230.43% above the...
Investing.com – U.S. stocks were lower after the close on Thursday, as losses in the Technology, Consumer Services and Consumer Goods sectors led shares lower. At the close in...
H.C. Wainwright analyst Patrick Trucchio maintained a Buy rating on uniQure (NASDAQ:QURE) N.V. on Thursday, setting a price target of $90, which is approximately 213.04% above the...
uniQure (NASDAQ:QURE) QURE shares soared 8.3% in the last trading session to close at $34.95. The move was backed by solid volume with far more shares changing hands than in a...
The NASDAQ registered its first closing high in more than two months on Monday, as the market gets ready for an important week that will see four of the five FAANGs and other...
UniQure (QURE) came out with a quarterly loss of $0.01 per share versus the Zacks Consensus Estimate of a loss of $0.78. This compares to loss of $0.97 per share a year ago. These...
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy that is in Phase I/II clinical study for the treatment of Huntington’s disease; AMT-060, which is in Phase I/II clinical trial for the treatment of hemophilia B; AMT-210, a product candidate for the treatment of Parkinson’s disease; AMT-260 for temporal lobe epilepsy; AMT-240, a preclinical product candidate for the treatment of autosomal dominant Alzheimer’s disease; and AMT-161 for the treatment of amyotrophic lateral sclerosis. uniQure N.V. was founded in 1998 and is headquartered in Amsterdam, the Netherlands.
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Neutral | Buy | Buy | Sell | Strong Sell |
| Technical Indicators | Strong Sell | Strong Buy | Strong Buy | Sell | Strong Sell |
| Summary | Sell | Strong Buy | Strong Buy | Sell | Strong Sell |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 93.12 | 94.34 | 87.10 | +4.35 | +4.90% | 3.51M | NASDAQ | |||
| 92.65 | 93.89 | 89.52 | +1.49 | +1.63% | 109.22M | NASDAQ | |||
| 114.98 | 119.00 | 102.54 | +9.51 | +9.02% | 4.44M | NYSE | |||
| 307.81 | 316.97 | 304.62 | -9.64 | -3.04% | 486.43K | NYSE | |||
| 82.31 | 84.07 | 81.07 | -0.16 | -0.19% | 22.86M | NYSE | |||
| 8.16 | 8.19 | 7.96 | -0.08 | -0.97% | 4.69M | NYSE | |||
| 237.51 | 247.19 | 232.39 | -5.64 | -2.32% | 1.53M | NYSE | |||
| 4.44 | 4.47 | 4.44 | 0.000 | 0.00% | 0.00 | NYSE | |||
| 130.85 | 133.00 | 126.28 | -1.21 | -0.92% | 5.32M | NASDAQ | |||
| 39.40 | 39.60 | 38.84 | +0.64 | +1.65% | 5.85M | NYSE | |||
| 0.1922 | 0.2025 | 0.1896 | -0.0158 | -7.60% | 1.43M | NYSE | |||
| 1.15 | 1.15 | 1.11 | +0.0200 | +1.77% | 4.63M | NYSE | |||
| 2.54 | 2.68 | 2.30 | +0.160 | +6.72% | 11.66M | NYSE | |||
| 232.61 | 234.61 | 230.82 | +0.30 | +0.13% | 1.02M | NYSE | |||
| 167.20 | 168.60 | 161.49 | +5.26 | +3.25% | 816.30K | NASDAQ |